acetazolamide has been researched along with Congenital X-Linked Retinoschisis in 11 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report on the efficacy of the oral carbonic anhydrase inhibitor (CAI) acetazolamide in treating macular retinoschisis (RS) in the rare vitreoretinal dystrophy best known as the enhanced S-cone syndrome (ESCS)." | 7.75 | Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. ( Eyestone, ME; Fung, KH; Iannaccone, A; Stone, EM, 2009) |
| "To report on the efficacy of the oral carbonic anhydrase inhibitor (CAI) acetazolamide in treating macular retinoschisis (RS) in the rare vitreoretinal dystrophy best known as the enhanced S-cone syndrome (ESCS)." | 3.75 | Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. ( Eyestone, ME; Fung, KH; Iannaccone, A; Stone, EM, 2009) |
| "X-linked retinoschisis was diagnosed in the patient after her retina exam revealed an area of retinoschisis and a foveal cyst." | 2.49 | X-linked juvenile retinoschisis in females and response to carbonic anhydrase inhibitors: case report and review of the literature. ( Ali, S; Seth, R, 2013) |
| "X-Linked Retinoschisis (XLRS) is a common genetically determined form of macular degeneration affecting young males." | 1.48 | The treatment of refractory angle-closure glaucoma in a patient with X-linked juvenile retinoschisis. ( Garway-Heath, DF; Low, S; Mohamed, R; Ting, M; Webster, AR, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Low, S | 1 |
| Mohamed, R | 1 |
| Ting, M | 1 |
| Webster, AR | 1 |
| Garway-Heath, DF | 1 |
| Testa, F | 1 |
| Di Iorio, V | 1 |
| Gallo, B | 1 |
| Marchese, M | 1 |
| Nesti, A | 1 |
| De Rosa, G | 1 |
| Melillo, P | 1 |
| Simonelli, F | 1 |
| Rocha Cabrera, P | 1 |
| Pareja Ríos, AC | 1 |
| Cordovés Dorta, L | 1 |
| Mantolán Sarmiento, C | 1 |
| Serrano García, MA | 1 |
| Gurbaxani, A | 1 |
| Wei, M | 1 |
| Succar, T | 1 |
| McCluskey, PJ | 1 |
| Jamieson, RV | 1 |
| Grigg, JR | 1 |
| Zhang, L | 1 |
| Reyes, R | 1 |
| Lee, W | 1 |
| Chen, CL | 1 |
| Chan, L | 1 |
| Sujirakul, T | 1 |
| Chang, S | 1 |
| Tsang, SH | 1 |
| Verbakel, SK | 1 |
| van de Ven, JP | 1 |
| Le Blanc, LM | 1 |
| Groenewoud, JM | 1 |
| de Jong, EK | 1 |
| Klevering, BJ | 1 |
| Hoyng, CB | 1 |
| Andreuzzi, P | 1 |
| Fishman, GA | 2 |
| Anderson, RJ | 1 |
| Iannaccone, A | 1 |
| Fung, KH | 1 |
| Eyestone, ME | 1 |
| Stone, EM | 1 |
| Thobani, A | 1 |
| Ali, S | 1 |
| Seth, R | 1 |
| Ghajarnia, M | 1 |
| Gorin, MB | 1 |
1 review available for acetazolamide and Congenital X-Linked Retinoschisis
| Article | Year |
|---|---|
X-linked juvenile retinoschisis in females and response to carbonic anhydrase inhibitors: case report and review of the literature.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Female; Humans; Middle Aged; Retinoschisis; Treatment | 2013 |
1 trial available for acetazolamide and Congenital X-Linked Retinoschisis
| Article | Year |
|---|---|
Acetazolamide in retinoschisis: a prospective study.
Topics: Acetazolamide; Adolescent; Adult; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Child; Child, Pr | 2014 |
9 other studies available for acetazolamide and Congenital X-Linked Retinoschisis
| Article | Year |
|---|---|
The treatment of refractory angle-closure glaucoma in a patient with X-linked juvenile retinoschisis.
Topics: Acetazolamide; Adult; Anticonvulsants; Glaucoma, Angle-Closure; Humans; Male; Retinoschisis; Treatme | 2018 |
Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; Electroretinography; Female; | 2019 |
A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis.
Topics: Acetazolamide; Administration, Topical; Adolescent; Carbonic Anhydrase Inhibitors; Humans; Male; Ret | 2014 |
Rapid resolution of retinoschisis with acetazolamide.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Electroretinography; Humans; Male; Ophthalmoscopy; Ret | 2015 |
Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis.
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Child; Dose-Response Relationship, Drug; F | 2016 |
USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Dose-Respo | 2017 |
Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.
Topics: Acetazolamide; Acute Disease; Administration, Oral; Carbonic Anhydrase Inhibitors; Electroretinograp | 2009 |
The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
Topics: Acetazolamide; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Humans; Macular Edema; Male; Reti | 2011 |
Acetazolamide in the treatment of X-linked retinoschisis maculopathy.
Topics: Acetazolamide; Administration, Oral; Carbonic Anhydrase Inhibitors; Child; Humans; Macular Edema; Ma | 2007 |